These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 31612072)

  • 21. Atrial Cardiopathy Biomarkers and MRI-Based Infarct Patterns in Patients with Embolic Strokes of Undetermined Source.
    Lee YK; Gwak BC; Yoon BA; Kim DH; Cha JK
    J Stroke Cerebrovasc Dis; 2021 Aug; 30(8):105933. PubMed ID: 34157668
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Plasma N-terminal protype-B natriuretic peptide and restrictive mitral flow to risk-stratify patients with stage B heart failure.
    Dini FL; Whalley G; Poppe K; Fontanive P; Rosa GM; Doughty RN; Di Bello V
    Clin Cardiol; 2009 Dec; 32(12):711-7. PubMed ID: 20027664
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The correlation of left atrial volume index to the level of N-terminal pro-BNP in heart failure with a preserved ejection fraction.
    Kim H; Jun DW; Cho YK; Nam CW; Han SW; Hur SH; Kim YN; Kim KB
    Echocardiography; 2008 Oct; 25(9):961-7. PubMed ID: 18771554
    [TBL] [Abstract][Full Text] [Related]  

  • 24. NT-proBNP levels and diastolic dysfunction in beta-thalassaemia major patients.
    Kremastinos DT; Tsiapras DP; Kostopoulou AG; Hamodraka ES; Chaidaroglou AS; Kapsali ED
    Eur J Heart Fail; 2007 May; 9(5):531-6. PubMed ID: 17317307
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Amount of left ventricular hypertrophy determines the plasma N-terminal pro-brain natriuretic peptide level in patients with hypertrophic cardiomyopathy and normal left ventricular ejection fraction.
    Kim SW; Park SW; Lim SH; Kwon SU; Choi YJ; Park MK; Lee SC; Lee SH; Park JE; Jeon ES
    Clin Cardiol; 2006 Apr; 29(4):155-60. PubMed ID: 16649724
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [NT-proBNP and echocardiography for long-term left ventricular function assessment after acute myocardial infarction treated with primary angioplasty].
    Swiatkiewicz I; Grubecki A; Koziński M; Fabiszak T; Białoszyński T; Sukiennik A; Kubica J
    Pol Merkur Lekarski; 2006 Mar; 20(117):289-92. PubMed ID: 16780257
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Simultaneous estimation of NT-proBNP on top to mitral flow Doppler echocardiography as an accurate strategy to diagnose diastolic dysfunction in HFNEF.
    Kasner M; Gaub R; Westermann D; Kaplan H; Akpulat S; Steendijk P; Schultheiss HP; Tschöpe C
    Int J Cardiol; 2011 May; 149(1):23-9. PubMed ID: 20053469
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Assessment of sustained effects of levosimendan and dobutamine on left ventricular systolic functions by using novel tissue Doppler derived indices in patients with advanced heart failure.
    Oner E; Erturk M; Birant A; Kurtar Mansıroglu A; Akturk IF; Karakurt H; Yalcin AA; Uzun F; Somuncu MU; Yildirim A
    Cardiol J; 2015; 22(1):87-93. PubMed ID: 24846511
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [The diagnostic value of N-terminal B-type natriuretic peptide in diastolic heart failure: comparison with echocardiographic findings].
    Tuğcu A; Yildirimtürk O; Aytekin S
    Turk Kardiyol Dern Ars; 2009 Mar; 37(2):112-21. PubMed ID: 19404033
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prevalence of left ventricular diastolic dysfunction in a general population.
    Kuznetsova T; Herbots L; López B; Jin Y; Richart T; Thijs L; González A; Herregods MC; Fagard RH; Díez J; Staessen JA
    Circ Heart Fail; 2009 Mar; 2(2):105-12. PubMed ID: 19808325
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The role of NT-proBNP in the diagnostics of isolated diastolic dysfunction: correlation with echocardiographic and invasive measurements.
    Tschöpe C; Kasner M; Westermann D; Gaub R; Poller WC; Schultheiss HP
    Eur Heart J; 2005 Nov; 26(21):2277-84. PubMed ID: 16014646
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Diastolic dysfunction and natriuretic peptides in systolic heart failure. Higher ANP and BNP levels are associated with the restrictive filling pattern.
    Yu CM; Sanderson JE; Shum IO; Chan S; Yeung LY; Hung YT; Cockram CS; Woo KS
    Eur Heart J; 1996 Nov; 17(11):1694-702. PubMed ID: 8922918
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The relationship between the time interval difference of isovolumic relaxation (T[IVRT-IVRTa]) and serum levels of N-terminal pro-brain natriuretic peptide in patients with intermediate E/Ea ratio.
    Zacharopoulou I; Mornoş C; Manolis AJ; Kouremenos N; Tsoukas A; Pittaras A; Poulimenos L; Drăgulescu SI
    Hellenic J Cardiol; 2011; 52(1):23-9. PubMed ID: 21292604
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Degree and distribution of left ventricular hypertrophy as a determining factor for elevated natriuretic peptide levels in patients with hypertrophic cardiomyopathy: insights from cardiac magnetic resonance imaging.
    Park JR; Choi JO; Han HJ; Chang SA; Park SJ; Lee SC; Choe YH; Park SW; Oh JK
    Int J Cardiovasc Imaging; 2012 Apr; 28(4):763-72. PubMed ID: 21516440
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prognostic value of N-terminal pro-type-B natriuretic peptide and Doppler left ventricular diastolic variables in patients with chronic systolic heart failure stabilized by therapy.
    Dini FL; Conti U; Fontanive P; Andreini D; Panicucci E; De Tommasi SM
    Am J Cardiol; 2008 Aug; 102(4):463-8. PubMed ID: 18678307
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The relationship of carotid arterial stiffness to left ventricular diastolic dysfunction in untreated hypertension.
    Jaroch J; Łoboz Grudzień K; Bociąga Z; Kowalska A; Kruszyńska E; Wilczyńska M; Dudek K
    Kardiol Pol; 2012; 70(3):223-31. PubMed ID: 22430399
    [TBL] [Abstract][Full Text] [Related]  

  • 37. N-terminal pro B-type natriuretic peptide levels: correlation with echocardiographically determined left ventricular diastolic function in an ambulatory cohort.
    Dong SJ; de las Fuentes L; Brown AL; Waggoner AD; Ewald GA; Dávila-Román VG
    J Am Soc Echocardiogr; 2006 Aug; 19(8):1017-25. PubMed ID: 16880097
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Tissue Doppler imaging adds incremental value in predicting exercise capacity in patients with congestive heart failure.
    Terzi S; Sayar N; Bilsel T; Enc Y; Yildirim A; Ciloğlu F; Yesilcimen K
    Heart Vessels; 2007 Jul; 22(4):237-44. PubMed ID: 17653517
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Echocardiographic assessment and N-terminal pro-brain natriuretic peptide in hypertensives with metabolic syndrome.
    Krzesiński P; Uziebło-Życzkowska B; Gielerak G; Stańczyk A; Piotrowicz K; Piechota W; Smurzyński P; Skrobowski A
    Adv Clin Exp Med; 2017; 26(2):295-301. PubMed ID: 28791849
    [TBL] [Abstract][Full Text] [Related]  

  • 40. N-terminal B-type natriuretic peptide and the association with left ventricular diastolic function in a population at high risk of incident heart failure: results of the SCReening Evaluationof the Evolution of New-Heart Failure Study (SCREEN-HF).
    McGrady M; Reid CM; Shiel L; Wolfe R; Boffa U; Liew D; Campbell DJ; Prior D; Krum H
    Eur J Heart Fail; 2013 May; 15(5):573-80. PubMed ID: 23338855
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.